Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 11, 2021, Adaptive Biotechnologies Corporation (the "Company") held its annual meeting of shareholders (the "Annual Meeting"). At the Annual Meeting, the Company's shareholders voted on four proposals, as described below. Each of the proposals was described in detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 23, 2021. The vote totals noted below are final voting results from the Annual Meeting.



   1. The Company's shareholders elected the following three Class II director
      nominees, each to hold office until the 2024 annual meeting of shareholders
      or until his or her successor is elected and qualified, by the vote set
      forth below:




                                  Votes        Broker
Nominee            Votes For     Withheld    Non-Votes
Michelle Griffin   95,779,979   12,600,796   14,450,327
Peter Neupert      92,865,432   15,515,343   14,450,327
Leslie Trigg       97,812,160   10,568,615   14,450,327




   2. The Company's shareholders approved, on a non-binding advisory basis, the
      2020 compensation of its named executive officers as described in the proxy
      statement based on the following results:




                                              Broker
 Votes For    Votes Against   Abstentions   Non-Votes
100,345,226     7,888,977       146,572     14,450,327




   3. The Company's shareholders approved, on a non-binding advisory basis, a
      frequency of one year for future advisory votes on named executive officers'
      compensation. After considering these results, we will hold a non-binding
      advisory vote on executive compensation on an annual basis until the next
      advisory vote on the frequency of non-binding votes on executive
      compensation.




                                                         Broker
 One Year     Two Years   Three Years   Abstentions    Non-Votes
107,470,826    18,789       870,697       20,461       14,450,327


   4. The Company's shareholders ratified the appointment of Ernst & Young LLP as
      the Company's independent registered public accounting firm for the fiscal
      year ending December 31, 2021 by the vote set forth below:




 Votes For    Votes Against   Abstentions
122,794,811      21,326         14,964

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses